Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

The exact causes of baldness are not fully understood, limiting treatment options.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Spironolactone plus finasteride reduces hirsutism more effectively.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

Finasteride improves hidradenitis suppurativa but not for child-bearing women.

PCOS is a hormonal issue in women that is usually treated with birth control pills, metformin, and lifestyle changes, with early treatment helping to reduce complications and improve life quality.

Metabolic syndrome reduces effectiveness of hair loss treatment.

Platelet-rich plasma treatment can significantly increase hair count and density in men with pattern baldness, and these improvements can last up to 3 months.

Herbs might help with hair loss, but more research is needed to confirm their safety and effectiveness.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Finasteride is a safe, effective treatment for hirsutism with fewer side effects.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Longer CAG repeats in gene linked to more severe hair loss in females.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Ketogenic diet, neurosteroids, and HMGB1-TLR4 signaling pathway are potential targets for new epilepsy treatments.

Androgens can both increase and decrease hair growth in different parts of the body.